Clinical Trials Browser

Disease, Ovarian Cysts, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03429387 2022-05-17

PIPPIN

Phase NA Completed

147 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT01613300 2021-05-26

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Phase 2 Completed

33 enrolled

Lymphoid

Disease, Lymphoma, B-Cell

NCT03755947 2021-02-02

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

3 enrolled

LymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04688463 2020-12-30

Evaluation of Pressure Algometry in the Clinical Assessment of Acute Abdominal Pain in Children

Completed

427 enrolled

LymphoidOther hematologic neoplasm

Appendicitis, Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01836484 2020-02-13

MAPPING

Completed

162 enrolled

GynecologicLymphoid

Uterine Cervical Neoplasms, Disease, Lymphoma, Follicular, Endometrial Neoplasms

NCT02337140 2016-12-01

TAVISTIM

Phase NA Completed

165 enrolled

Lymphoid

Aortic Valve Stenosis, Disease, Lymphoma, Follicular

NCT00748319 2012-08-22

KIR

Phase NA Completed

495 enrolled

DermatologicLymphoid

Dermatitis, Dermatitis, Exfoliative, Disease, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Clinical Trials

OvaMa-PEDs

PIPPIN

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Evaluation of Pressure Algometry in the Clinical Assessment of Acute Abdominal Pain in Children

MAPPING

TAVISTIM

KIR